FIELD: medicine; pharmacology.
SUBSTANCE: new discovered pyrimidine compounds of formula 
where R1-R9 are those as specified are selective inhibitors of group Src of nonreceptor tyrosine kinases. These compounds and their pharmaceutically acceptable salts are antiproliferative agents applied for treatment and fight against solid tumours, specifically breast tumours, rectum tumours, liver and pancreatic tumours.
EFFECT: applicable for cancer treatment.
17 cl, 5 dwg, 16 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF PYRIMIDO [4,5-d]PYRIMIDINE, WHICH HAVE ANTICANCER ACTIVITY | 2003 |
|
RU2331641C2 |
| 3,4-DISUBSTITUTED CYCLOBUTENE-1,2-DIONES AS LIGANDS OF CXC-CHEMOKINE RECEPTOR | 2002 |
|
RU2344123C9 |
| DERIVATIVES OF 2-AMINO-4H-3,1-BENZOXAZINE-4-ONE FOR PROPHYLAXIS OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2244711C2 |
| DERIVATIVES OF 2-OXY-4H-3,1-BENZOXAZINE-2-ONE FOR PROPHYLAXIS AND/OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2245331C2 |
| PYRIMIDINE COMPOUNDS WITH SELECTIVE INHIBITION OF "¦-¦" AND "L¦L¦" ACTIVITY | 2004 |
|
RU2350617C2 |
| BENZOTHIEPINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC STATE | 1997 |
|
RU2202549C2 |
| THIENO-(1,3)-OXAZINE-4-ONS POSSESSING INHIBITING ACTIVITY IN RESPECT TO LIPASE | 2002 |
|
RU2324696C2 |
| COMBINED TREATMENT USING BENZOTHIEPINS INHIBITING TRANSPORT OF BILE ACID IN JEJUNUM AND INHIBITORS OF HMG-COA-REDUCTASE | 1998 |
|
RU2247579C2 |
| N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS | 2010 |
|
RU2553681C2 |
| BICYCLICAL NITROGEN-CONTAINING HETEROCYCLES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 1999 |
|
RU2256662C2 |
